Department of Endocrinology and Metabolism, Graduate School of Medical Science, and Kyoto Prefectural University of Medicine, Kyoto, Japan.
Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.
Diabetes Technol Ther. 2021 Jan;23(1):78-80. doi: 10.1089/dia.2020.0237. Epub 2020 Jul 15.
Diabetes is associated with mortality and severity of coronavirus disease (COVID-19). Protecting against infection in health care workers at high risk of COVID-19 is critical. This report investigates the usefulness and safety of remote continuous glucose monitoring (CGM) in a patient with diabetes and severe interstitial pneumonia caused by the coronavirus disease. The Dexcom G4 Platinum CGM system was used to monitor blood glucose (BG) levels from outside the patient's isolation room. Continuous insulin infusion rates and boluses were determined based on the patient's BG levels. Real-time CGM made it possible to track BG trends and prevent dramatic variations in BG, although the rate of insulin infusion changed dynamic. Furthermore, the need for health care workers to enter the isolation room was minimized because the Dexcom G4 Platinum CGM system can evaluate from a distance of up to 6.0 m.
糖尿病与冠状病毒病（COVID-19）的死亡率和严重程度相关。保护高风险 COVID-19 医护人员免受感染至关重要。本报告调查了远程连续血糖监测（CGM）在一名因冠状病毒病引起严重间质性肺炎的糖尿病患者中的有效性和安全性。使用 Dexcom G4 Platinum CGM 系统监测患者隔离病房外的血糖（BG）水平。根据患者的 BG 水平确定连续胰岛素输注率和推注量。实时 CGM 可以跟踪 BG 趋势并防止 BG 大幅波动，尽管胰岛素输注率发生了动态变化。此外，由于 Dexcom G4 Platinum CGM 系统最远可在 6.0 米的距离进行评估，因此医护人员进入隔离病房的必要性降到最低。
